Aethlon Medical, Inc. (AEMD)
Filters blood to remove harmful substances in patients with cancer and severe infections.
$0.56+0.00%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-95.1%
The outlook
AEMD is trading near its 52-week low, well below both its 50- and 200-day moving averages, reflecting weak recent momentum. Analyst coverage shows a wide gap, with the average price target sitting roughly 477% above the current price, though this reflects minimal consensus. The overall sentiment leans bearish based on current technicals.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range0% of the way from its 52-week low to high
Price targetAvg target +477% vs current price
Analyst price target
~12-month · 2 analysts$3.25average target+476.5% vs now
Now $0.56
Low $1.50High $5.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$1.5M
52-wk high
$27.40
52-wk low
$0.54
50-day avg
$1.46
200-day avg
$2.69
Trailing P/E
—